Funder: National Institutes of Health
Due Dates: July 8, 2025 (Letter of Intent) | August 7, 2025 (Application)
Funding Amounts: Up to $300,000 direct costs/year for up to 5 years (max $1.5M direct costs), plus applicable F&A; 5–6 awards/year
Summary: Supports early-stage investigators proposing innovative research in the chemistry and pharmacology of substance use disorders; preliminary data not required.
Key Information: Clinical trials are not allowed; applicants must meet NIH Early Stage Investigator (ESI) criteria at submission.